KalVista Pharmaceuticals, Inc.

KALVDelisted Jun 11, 2026

Industry: Pharmaceutical Preparations
SEC CIK: 0001348911

SEC filings (opens in a new tab)

KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.

Q3 2025 vs. Q2 2025

How the institutions holding KalVista Pharmaceuticals, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025 All holders in Q2 2025

13F holders of KALV: Q2 2025 compared with Q3 2025
Measure	Q2 2025	Of which not filed for Q3 2025	Q3 2025	Change
Holders	140	2	145	+7
Shares	54.4M	10.2K	58.6M	+4.18M (+7.7%)
Value	$615.5M	$115.2K	$714.0M	+$98.6M (+16.0%)

2 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (31)

Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to KALV in Q3 2025
Institution	Shares	Value	% of portfolio
Freestone Grove Partners LP	704,448	$8.58M	0.06%
Sio Capital Management, LLC	683,819	$8.33M	2.11%
Kynam Capital Management, LP	606,171	$7.38M	0.55%
Jefferies Financial Group Inc.	286,875	$3.49M	0.03%
SummitTX Capital, L.P.	143,561	$1.75M	0.07%
Caption Management, LLC	141,422	$1.72M	0.10%
Blue Owl Capital Holdings LP	125,000	$1.52M	0.47%
Swiss National Bank	48,500	$590.7K	0.00%
SG Americas Securities, LLC	41,620	$507.0K	0.00%
Artia Global Partners LP	41,555	$506.1K	0.09%
HAP Trading, LLC	31,219	$380.2K	0.10%
Magnetar Financial LLC	26,924	$327.9K	0.00%
Capstone Investment Advisors, LLC	21,421	$260.9K	0.00%
Axq Capital, LP	17,213	$209.7K	0.08%
DRW Securities, LLC	16,775	$196.0K	0.01%
Sherbrooke Park Advisers LLC	15,678	$191.0K	0.09%
Quantinno Capital Management LP	14,158	$172.4K	0.00%
UBS Asset Management Americas Inc	13,600	$165.6K	0.00%
SEI Investments Co	11,896	$144.9K	0.00%
Janus Henderson Group PLC	10,900	$132.9K	0.00%
KLP Kapitalforvaltning AS	5,200	$63.3K	0.00%
Wolverine Asset Management LLC	4,662	$56.8K	0.00%
Zurcher Kantonalbank (Zurich Cantonalbank)	4,545	$55.4K	0.00%
SRS Capital Advisors, Inc.	971	$11.8K	0.00%
Quadrant Capital Group LLC	777	$9.46K	0.00%
Smartleaf Asset Management LLC	253	$3.09K	0.00%
Optiver Holding B.V.	210	$2.56K	0.00%
Caitong International Asset Management Co., Ltd	102	$1.24K	0.00%
CoreCap Advisors, LLC	23	$280	0.00%
Sunbelt Securities, Inc.	18	$219	0.00%
Bessemer Group Inc	10	$0	0.00%

Sold out (24)

Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of KALV in Q3 2025
Institution	Shares, Q2 2025	Value, Q2 2025
Great Point Partners LLC	323,170	$3.65M
First Turn Management, LLC	214,138	$2.42M
Ikarian Capital, LLC	198,528	$2.24M
Rosalind Advisors, Inc.	157,725	$1.78M
Stonepine Capital Management, LLC	100,000	$1.13M
UBS Oconnor LLC	79,460	$898.3K
Saturn V Capital Management LLC	62,793	$709.9K
Allostery Investments LP	40,000	$452.2K
Omers Administration Corp	33,900	$383.2K
Virtu Financial LLC	30,739	$347.0K
Squarepoint Ops LLC	26,386	$298.3K
Engineers Gate Manager LP	26,257	$296.8K
Quadrature Capital Ltd	19,973	$225.9K
Quarry LP	16,796	$189.9K
Atom Investors LP	16,312	$184.4K
Citadel Advisors LLC	15,841	$179.1K
Trexquant Investment LP	12,781	$144.5K
Whalen Wealth Management Inc.	10,938	$123.7K
Voya Investment Management LLC	10,714	$121.1K
Group One Trading, L.P.	4,963	$56.1K
Simplex Trading, LLC	3,543	$40.0K
Bryn Mawr Trust Co	415	$4.69K
Skopos Labs, Inc.	244	$2.76K
UMA Financial Services, Inc.	51	$577

Not filed for Q3 2025 yet (2)

Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding KALV in Q2 2025 that haven't filed for Q3 2025
Institution	Shares, Q2 2025	Value, Q2 2025
Martin Worley Group	10,168	$114.9K
Parkworth Wealth Management, Inc.	22	$249